Central Trust Company’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.4M Buy
14,657
+404
+3% +$38.8K 0.03% 305
2026
Q1
$1.48M Buy
14,253
+467
+3% +$52.9K 0.03% 286
2025
Q4
$1.39M Buy
13,786
+711
+5% +$77.2K 0.03% 291
2025
Q3
$1.61M Sell
13,075
-320
-2% -$39.7K 0.03% 282
2025
Q2
$1.61M Sell
13,395
-478
-3% -$63.8K 0.04% 274
2025
Q1
$2.04M Sell
13,873
-916
-6% -$140K 0.05% 234
2024
Q4
$2.4M Sell
14,789
-1,803
-11% -$295K 0.06% 219
2024
Q3
$2.7M Sell
16,592
-1,739
-9% -$258K 0.06% 202
2024
Q2
$2.5M Sell
18,331
-8,993
-33% -$1.25M 0.06% 208
2024
Q1
$4.18M Sell
27,324
-3,022
-10% -$451K 0.1% 159
2023
Q4
$4.33M Sell
30,346
-2,074
-6% -$277K 0.12% 141
2023
Q3
$4.25M Sell
32,420
-271
-0.8% -$41.2K 0.12% 137
2023
Q2
$5.2M Buy
32,691
+2,030
+7% +$327K 0.15% 122
2023
Q1
$4.85M Sell
30,661
-103
-0.3% -$15.4K 0.14% 125
2022
Q4
$4.32M Buy
30,764
+325
+1% +$46.1K 0.13% 133
2022
Q3
$3.91M Sell
30,439
-490
-2% -$70.7K 0.13% 135
2022
Q2
$4.36M Sell
30,929
-83
-0.3% -$11.9K 0.14% 122
2022
Q1
$4.31M Sell
31,012
-1,777
-5% -$272K 0.12% 144
2021
Q4
$5.72M Sell
32,789
-1,115
-3% -$186K 0.16% 122
2021
Q3
$5.61M Sell
33,904
-1,734
-5% -$299K 0.2% 107
2021
Q2
$6.41M Sell
35,638
-2,663
-7% -$486K 0.23% 94
2021
Q1
$7.39M Buy
38,301
+886
+2% +$171K 0.29% 80
2020
Q4
$7.55M Sell
37,415
-447
-1% -$92.5K 0.31% 74
2020
Q3
$7.96M Buy
37,862
+320
+0.9% +$71.3K 0.36% 69
2020
Q2
$8.24M Buy
37,542
+3,102
+9% +$620K 0.41% 60
2020
Q1
$5.97M Sell
34,440
-194
-0.6% -$32.1K 0.37% 65
2019
Q4
$5.32M Sell
34,634
-1,271
-4% -$190K 0.27% 89
2019
Q3
$5.45M Sell
35,905
-265
-0.7% -$41.9K 0.31% 81
2019
Q2
$5.62M Sell
36,170
-2,066
-5% -$316K 0.32% 77
2019
Q1
$6.14M Sell
38,236
-382
-1% -$59.3K 0.37% 67
2018
Q4
$5.95M Sell
38,618
-60
-0.2% -$9.35K 0.4% 60
2018
Q3
$5.82M Sell
38,678
-636
-2% -$90.3K 0.34% 72
2018
Q2
$5.32M Sell
39,314
-1,927
-5% -$238K 0.34% 67
2018
Q1
$5.49M Sell
41,241
-1,560
-4% -$210K 0.35% 65
2017
Q4
$6.37M Buy
42,801
+2,959
+7% +$403K 0.39% 65
2017
Q3
$5.26M Buy
39,842
+763
+2% +$103K 0.34% 74
2017
Q2
$5.21M Sell
39,079
-1,205
-3% -$163K 0.34% 78
2017
Q1
$5.43M Sell
40,284
-2,469
-6% -$320K 0.36% 74
2016
Q4
$5.13M Buy
42,753
+10,137
+31% +$1.2M 0.35% 75
2016
Q3
$4.08M Sell
32,616
-518
-2% -$67.8K 0.3% 92
2016
Q2
$4.58M Sell
33,134
-717
-2% -$93K 0.34% 81
2016
Q1
$4.27M Sell
33,851
-3,001
-8% -$381K 0.34% 80
2015
Q4
$4.67M Sell
36,852
-511
-1% -$63.4K 0.39% 66
2015
Q3
$4.32M Sell
37,363
-910
-2% -$102K 0.38% 71
2015
Q2
$3.98M Sell
38,273
-141
-0.4% -$15.2K 0.31% 83
2015
Q1
$4.24M Sell
38,414
-418
-1% -$45.4K 0.34% 74
2014
Q4
$4.05M Sell
38,832
-6,061
-14% -$606K 0.33% 79
2014
Q3
$4.31M Sell
44,893
-2,050
-4% -$185K 0.34% 72
2014
Q2
$4.29M Sell
46,943
-1,710
-4% -$153K 0.34% 78
2014
Q1
$4.28M Buy
48,653
+115
+0.2% +$10.1K 0.35% 73
2013
Q4
$4.5M Sell
48,538
-280
-0.6% -$25.2K 0.38% 69
2013
Q3
$3.99M Buy
48,818
+6,062
+14% +$512K 0.36% 69
2013
Q2
$3.55M Buy
+42,756
New +$3.68M 0.34% 71

Other funds holding CLX

Central Trust Company's CLX Position: Q2 2026 in Review

Central Trust Company increased its Clorox (CLX) stake by 2.8% in Q2 2026, buying an estimated $38.8K and bringing the position to 14,657 shares worth $1.4M. The position accounts for 0.03% of the portfolio, ranked #305.

Central Trust Company first reported a position in CLX in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.24M in Q2 2020. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Central Trust Company held 14,657 shares of Clorox worth $1.4M as of Q2 2026.
  • Central Trust Company bought 404 Clorox shares in Q2 2026, an estimated $38.8K.
  • Clorox made up 0.03% of Central Trust Company's portfolio in Q2 2026, its #305 holding.
  • Central Trust Company first reported a position in Clorox in Q2 2013 and has held it in 53 quarters since.
  • Central Trust Company's Clorox position peaked at $8.24M in Q2 2020.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.